Osteoporosis treatment after hip fracture: Slow progress

Journal of Clinical Rheumatology

Volumn 11, Issue 2, 2005, Pages 65-67

  Pullman Mooar, Sally ^a,b   Mooar, Pekka ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; COLECALCIFEROL; ETIDRONIC ACID; RALOXIFENE; ZOLEDRONIC ACID;

BONE DENSITY; COMORBIDITY; DIET SUPPLEMENTATION; EDITORIAL; FRACTURE HEALING; HIGH RISK PATIENT; HIP FRACTURE; OSTEOPOROSIS; PRIORITY JOURNAL;

AGED; BONE DENSITY CONSERVATION AGENTS; CALCIUM; DIPHOSPHONATES; HIP FRACTURES; HUMANS; OSTEOPOROSIS; RECURRENCE; VITAMIN D;

EID: 17744371333     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rhu.0000159932.51274.d0     Document Type: Editorial

References (15)

1. Kamel HK. Secondary prevention of hip fractures among hospitalized elderly: are we doing enough? J Clin Rheum. 2005;11:68-71.
2. Elliot-Gibson V, Bogoch ER, Jamal SA, et al. Practice patterns in the diagnosis and treatment of osteoporosis after fragility fracture: a systematic review. Osteoporosis Int. 2004;15:767-778.
3. Doetsch AM, Faber J, Lynnerup N, et al. The effect of calcium and vitamin D3 supplementation on the healing of the proximal humerus fracture: a randomized placebo controlled trial. Calcif Tissue Int. 2004;75:183-188.
4. Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res. 2004;19:370-378.
5. Sato Y, Kanoko T, Satoh K, et al. Menatetranone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease. Bone. 2005;36:61-68.
6. Bendich A, Leader S, Muhuri P. Supplemental calcium for the prevention of hip fracture: potential health-economic benefits. Clin Ther. 1999;21:1058-1072.
7. Li J, Kaji Y, Mashiba T, et al. Effect of bisphophonate (incadronate) on fracture healing of long bones in rats. J Bone Miner Res. 1999;14: 969-979.
8. Peter CP, Cook WO, Nunamaker DM, et al. Effect of alendronate on fracture healing and bone remodeling in dogs. J Orthop Res. 1996;14: 74-79.
9. Li C, Mori S, Li J, et al. Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats. J Bone Miner Res. 2001;16:429-436.
10. Boonen S, McClung MR, Eastell R, et al. Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and the oldest old. J Am Geriatr Soc. 2004;52:1832-1839.
11. Colon-Emeric CS, Caminis J, Suh TT, et al. HORIZON Recurrent fracture trial. Curr Med Res Opin. 2004;20:903-910.
12. Kern L, Powe N, Levine M, et al. Association between screening for osteoporosis and the incidence of hip fracture. Annals of Int Med. 2005;142:173-181.
13. Gardner MJ, Flik KR, Mooar P, et al. Improvement in the under treatment of osteoporosis following hip fracture. J Bone Joint Surg Am. 2002;84-A:1342-1348.
14. Smith MD, Ross W, Ahern MJ. Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures. J Rheum. 2001;28: 2504-2508.
15. Pearse EO, Redfern DJ, Sinha M, et al. Outcome following a second hip fracture. Injury. 2003;34:518-521.